Paj 1 soti nan 25 rezilta yo
STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT
Not applicable.
FIELD OF THE INVENTION
The invention relates to the treatment of tissue including cancerous tumors, and, more specifically, to systems and methods for implanting ferroelectric particles into tumorous tissue regions and
CROSS-REFERENCE TO RELATED APPLICATION
This application is the U.S. national stage application of International Patent Application No. PCT/EP2012/059799, filed May 25, 2012.
The Sequence Listing for this application is labeled "Seq-List-replace-2.txt" which was created on Jul. 10, 2015 and is 21 KB.
BACKGROUND
1. Field of Invention
This invention relates to hyperthermia and immunotherapy for treatment of cancer.
BACKGROUND
2. Description of Prior Art
The earliest references to treating cancer with hyperthermia can be found in Egyptian papyrus scrolls dated back to 3000 BC describing a breast
BACKGROUND
1. Field of Invention
This invention relates to hyperthermia and immunotherapy for treatment of cancer.
2. Description of Prior Art
The earliest references to treating cancer with hyperthernia can be found in Egyptian papyrus scrolls dated back to 3000 BC describing a breast cancer
CROSS-REFERENCE TO RELATED APPLICATIONS
Not applicable.
STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT
Not applicable.
FIELD OF THE INVENTION
The invention relates to the treatment of tissue including cancerous tumors, and, more specifically, to systems and methods for implanting
SUMMARY OF THE INVENTION
The present invention relates to a pharmaceutical composition formed by an amide bonding between a highly pure antibody to tumour antigen and an antitumour substance.
The first characteristic aspect of the present invention is to provide a pharmaceutical composition which
INTRODUCTION
Field of the Invention
Aspects of the invention are directed to administration of a composition comprising one or more generally regarded as safe (GRAS) compounds selected from the group of components consisting of vitamins, selenium, fatty acids, fatty acid salts, and fatty acid
INTRODUCTION
Field of the Invention
Aspects of the invention are directed to administration of a composition comprising one or more generally regarded as safe (GRAS) compounds selected from the group of components consisting of vitamins, selenium, fatty acids, fatty acid salts, and fatty acid
SUMMARY OF THE INVENTION
The present invention relates to a pharmaceutical composition formed by an amide bonding between a highly pure antibody to tumor (especially, cancer) antigen and an antitumor substance (antineoplastic agent).
The first characteristic aspect of the present invention is to
FIELD OF INVENTION
The present invention relates to a magnetic nanoparticle for tumor therapy, and particularly to a magnetic nanoparticle including an antibody and an anti-tumor drug, which achieves effective treatment of tumor therapy by synergistic effects between hyperthermia and targeted
BACKGROUND OF THE INVENTION
1. Field of The Invention
The present invention relates to the use of selected chiral carbohydrates in cancer therapy and processes for their application. More particularly, the invention relates to the use of L-isomers of monosaccharides having cytotoxic and cytostatic
FIELD OF THE INVENTION
The present invention relates to the use of selected chiral carbohydrates in cancer therapy and processes for their application. More particularly, the invention relates to the use of L-isomers of monosaccharides having cytotoxic and cytostatic properties. The selected
FIELD OF THE INVENTION
The present invention generally relates to control of gene expression in tumor cells. Specifically, the present invention provides methods for using a heat inducible promoter operatively linked to a therapeutic gene to preferably induce both immune and anti-angiogenic
BACKGROUND OF THE INVENTION
The invention relates generally to the use of sesquiterpene lactones in the treatment of infections caused by Flaviviridae and, more specifically, to the use of sesquiterpene lactone endoperoxides to treat hepatitis C infections, yellow fever, dengue fever, bovine viral
FIELD OF THE INVENTION
The invention relates generally to the field of treatment of invasive agents, such as pathogens and cancers, in living organisms such as the human body and, more particularly, to a system that generates an energy field for application to the living organism, to activate